For research use only. Not for therapeutic Use.
CJOC42(CAT: I024843) is a potent and selective inhibitor of gankyrin, an ankyrin-repeat oncoprotein overexpressed in various cancers. By binding to gankyrin in a dose-dependent manner, CJOC42 prevents the degradation of p53 protein levels typically associated with high gankyrin activity. This restoration of p53 functionality enhances p53-dependent transcription and sensitizes cancer cells to DNA damage. CJOC42 is a valuable tool for oncology research, particularly in studying gankyrin’s role in tumorigenesis and developing therapies that leverage p53 reactivation to combat cancer progression. Its specificity and efficacy make it a promising candidate for preclinical studies targeting gankyrin-driven malignancies.
Catalog Number | I024843 |
CAS Number | 2171519-89-2 |
Synonyms | CJOC42; CJOC-42; CJOC 42; |
Molecular Formula | C20H21N3O5S |
Purity | 98% |
Target | MDM-2/p53 |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | Methyl 4-(4-(3-(tosyloxy)propyl)-1H-1,2,3-triazol-1-yl)benzoate |
InChI | InChI=1S/C20H21N3O5S/c1-15-5-11-19(12-6-15)29(25,26)28-13-3-4-17-14-23(22-21-17)18-9-7-16(8-10-18)20(24)27-2/h5-12,14H,3-4,13H2,1-2H3 |
InChIKey | VYUDJPGSULLWAS-UHFFFAOYSA-N |
SMILES | O=C(OC)C1=CC=C(N2N=NC(CCCOS(=O)(C3=CC=C(C)C=C3)=O)=C2)C=C1 |